International Journal of Drug Development and Research

  • ISSN: 0975-9344
  • Journal h-index: 49
  • Journal CiteScore: 11.20
  • Journal Impact Factor: 8.24
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Euro Pub
  • Google Scholar
  • Secret Search Engine Labs
  • ResearchGate
Share This Page


Drug Resistant Mycobacterium tuberculosis and New Drug Development

Dipali M. Patel, Sweta D. Patel, Priyanka S. Jaiswal, Kinjal J. Brahmbhatt

Mycobacterium tuberculosis is an extraordinarily successful human pathogen, infecting one-third of the world’s population and causing nearly two million deaths each year. In this article, current trends in worldwide tuberculosis (TB) resistance are discussed along with pathogenesis of drug resistance, emergence of resistance, mechanism of resistance development, prevention of drug resistance and new drug development. The global TB emergency has been further exacerbated by multi drug-resistant (MDR) TB and extensively drug-resistant (XDR) TB strains that are resistant to our best antibiotics and very difficult to treat. Finally, this review briefly describes new antituberculosis drugs and the impetus for discovering new antibacterial compounds to target drug resistant M. tuberculosis and improve tuberculosis therapy.